Literature DB >> 20190889

IMPACT after 17 years: Lessons learned about successful networking.

.   

Abstract

Year:  2009        PMID： 20190889      PMCID： PMC2690519     

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  7 in total

1.  Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

Authors:  David W Scheifele; Scott A Halperin
Journal:  Semin Pediatr Infect Dis       Date:  2003-07

2.  Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002.

Authors:  Dorothy L Moore; Nicole Le Saux; David Scheifele; Scott A Halperin
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

3.  Incorporating vaccine-preventable disease surveillance into the National Health Information Network: leveraging children's hospitals.

Authors:  Andrew M Fine; Donald A Goldmann; Peter W Forbes; Sion K Harris; Kenneth D Mandl
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

4.  Thrombocytopenia after immunization of Canadian children, 1992 to 2001.

Authors:  Taj Jadavji; David Scheifele; Scott Halperin
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

5.  Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

Authors:  Nicole Le Saux; Nicholas J Barrowman; Dorothy L Moore; Sharon Whiting; David Scheifele; Scott Halperin
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

6.  Enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit.

Authors:  Yvonne A Zurynski; David Lester-Smith; Marino S Festa; Alison M Kesson; Robert Booy; Elizabeth J Elliott
Journal:  Commun Dis Intell Q Rep       Date:  2008-03

7.  Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006.

Authors:  Anne McNicholas; Yvonne Galloway; Paul Stehr-Green; Stewart Reid; Sarah Radke; Kerry Sexton; Charlotte Kieft; Claire Macdonald; Jocelyn Neutze; Ross Drake; Dorothy Isaac; Mary O'Donnell; Michael Tatley; Philipp Oster; Jane O'Hallahan
Journal:  Hum Vaccin       Date:  2007-05-18
  7 in total
  1 in total

1.  Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.

Authors:  Yousif Murad; Te-Yu Hung; Manish Sadarangani; Shaun K Morris; Nicole Le Saux; Otto G Vanderkooi; James D Kellner; Gregory J Tyrrell; Irene Martin; Walter Demczuk; Scott A Halperin; Julie A Bettinger; N Bridger; Cheryl Foo; S A Halperin; K A Top; R Thibeault; D Moore; J Papenburg; M Lebel; N Le Saux; S Morris; J Embree; B Tan; Athena McConnell; T Jadavji; C Constantinescu; W Vaudry; D Scheifele; M Sadarangani; J Bettinger; L Sauvé
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.